143 related articles for article (PubMed ID: 37036724)
21. [ANCA-associated vasculitis].
Holle JU
Z Rheumatol; 2013 Jun; 72(5):445-56. PubMed ID: 23743987
[TBL] [Abstract][Full Text] [Related]
22. Anti-neutrophil cytoplasmic antibody monitoring in vasculitis patients to predict relapse.
Schuster DD; Gillis D; Wong RCW; Kodituwakku A; Droney L; Ranganathan D
Int J Rheum Dis; 2023 Sep; 26(9):1861-1865. PubMed ID: 37183714
[No Abstract] [Full Text] [Related]
23. A case of anti-neutrophil cytoplasmic antibody-associated vasculitis masquerading as Sjögren syndrome.
Pillay SS; Nune A; Manzo C; Barman B; Raza H
Int J Rheum Dis; 2023 Dec; 26(12):2555-2558. PubMed ID: 37427846
[TBL] [Abstract][Full Text] [Related]
24. The future of ANCA-associated vasculitis.
Holle JU; Wieczorek S; Gross WL
Rheum Dis Clin North Am; 2010 Aug; 36(3):609-21. PubMed ID: 20688253
[TBL] [Abstract][Full Text] [Related]
25. [Primary systemic ANCA-associated vasculitis--recommendations concerning diagnosis and treatment].
Wiatr E; Gawryluk D
Pneumonol Alergol Pol; 2013; 81(5):479-91. PubMed ID: 23996888
[No Abstract] [Full Text] [Related]
26. Ectopic Relapse of Anti-neutrophil Cytoplasmic Antibody-associated Pituitary Vasculitis with No Elevation of Anti-neutrophil Cytoplasmic Antibodies after Renal Remission.
Muto R; Inagaki K; Sato N; Sameshima T; Nagakura Y; Baba S; Kato N; Maruyama S; Akahori T
Intern Med; 2020 Dec; 59(24):3187-3193. PubMed ID: 32788533
[TBL] [Abstract][Full Text] [Related]
27. Off-trial evaluation of the B cell-targeting treatment in the refractory cases of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis: long-term follow-up from a single centre.
Pullerits R; Ljevak M; Vikgren J; Bokarewa M
Scand J Immunol; 2012 Oct; 76(4):411-20. PubMed ID: 22823472
[TBL] [Abstract][Full Text] [Related]
28. Successful treatment with rituximab in a patient with TTP secondary to severe ANCA-associated vasculitis.
Asamiya Y; Moriyama T; Takano M; Iwasaki C; Kimura K; Ando Y; Aoki A; Kikuchi K; Takei T; Uchida K; Nitta K
Intern Med; 2010; 49(15):1587-91. PubMed ID: 20686295
[TBL] [Abstract][Full Text] [Related]
29. A case of haemoptysis, cutaneous leucocytoclastic vasculitis and positive ANCA--immunosuppression or not?
Sureshkumar R; Chin G
Intern Med J; 2010 Dec; 40(12):e3-4. PubMed ID: 21260955
[No Abstract] [Full Text] [Related]
30. Hepatitis B virus induced cytoplasmic antineutrophil cytoplasmic antibody-mediated vasculitis causing subarachnoid hemorrhage, acute transverse myelitis, and nephropathy: a case report.
Joshi U; Subedi R; Gajurel BP
J Med Case Rep; 2017 Apr; 11(1):91. PubMed ID: 28366165
[TBL] [Abstract][Full Text] [Related]
31. Outcome of Kidney Transplant in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Buttigieg J; Henderson L; Kidder D
Exp Clin Transplant; 2017 Oct; 15(5):509-515. PubMed ID: 27765007
[TBL] [Abstract][Full Text] [Related]
32. Update on clinical, pathophysiological and therapeutic aspects in ANCA-associated vasculitides.
Lamprecht P; Holle J; Gross WL
Curr Drug Discov Technol; 2009 Dec; 6(4):241-51. PubMed ID: 20025591
[TBL] [Abstract][Full Text] [Related]
33. Calling on dermatology to save a life: a case of MPO-ANCA-associated vasculitis.
Nogueira M; Machado Á; Coelho A; Raposo I
Eur J Dermatol; 2021 Dec; 31(6):852-853. PubMed ID: 35107078
[No Abstract] [Full Text] [Related]
34. Systemic vasculitis: an annual critical digest of the most recent literature.
Della Rossa A; Cioffi E; Elefante E; Ferro F; Parma A; Vagelli R; Talarico R
Clin Exp Rheumatol; 2014; 32(3 Suppl 82):S98-105. PubMed ID: 24854379
[TBL] [Abstract][Full Text] [Related]
35. Esophageal Sinus in a Patient With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Chen R; Liu X; Hao J
Am J Gastroenterol; 2020 Aug; 115(8):1158. PubMed ID: 31651445
[No Abstract] [Full Text] [Related]
36. Central Diabetes Insipidus in Refractory Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Ohashi K; Morishita M; Watanabe H; Sada KE; Katsuyama T; Miyawaki Y; Katsuyama E; Narazaki M; Tatebe N; Watanabe K; Kawabata T; Wada J
Intern Med; 2017 Nov; 56(21):2943-2948. PubMed ID: 28943556
[TBL] [Abstract][Full Text] [Related]
37. An unusual presentation of C-ANCA vasculitis.
Gavrilovski M; Kakar P; Rendle J; Lawrence E; Kee K; Sathanathan R
QJM; 2012 Nov; 105(11):1105-7. PubMed ID: 21920993
[No Abstract] [Full Text] [Related]
38. Issues in trial design for ANCA-associated and large-vessel vasculitis.
Tarzi RM; Mason JC; Pusey CD
Nat Rev Rheumatol; 2014 Aug; 10(8):502-10. PubMed ID: 24798573
[TBL] [Abstract][Full Text] [Related]
39. [ANCA-associated vasculitis after achieving remission].
Hellmich B
Z Rheumatol; 2020 Sep; 79(7):696-701. PubMed ID: 32588128
[No Abstract] [Full Text] [Related]
40. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis.
Kawakami T
J Dermatol; 2010 Feb; 37(2):113-24. PubMed ID: 20175844
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
